BRUCE D. BROUSSARD - 01 Jul 2024 Form 4 Insider Report for HUMANA INC (HUM)

Role
Chief Executive Officer, Director
Signature
Bruce D. Broussard
Issuer symbol
HUM
Transactions as of
01 Jul 2024
Net transactions value
$0
Form type
4
Filing time
01 Jul 2024, 10:27:40 UTC
Previous filing
24 Apr 2024
Next filing
16 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HUM Humana Common 85,130 01 Jul 2024 Direct F8
holding HUM Humana Common 25,000 01 Jul 2024 See Footnote F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HUM Options 13,430 01 Jul 2024 Humana Common 13,430 $350.79 Direct F1
holding HUM Options 30,425 01 Jul 2024 Humana Common 30,425 $376.61 Direct F2
holding HUM Options 23,734 01 Jul 2024 Humana Common 23,734 $425.06 Direct F3
holding HUM Options 26,484 01 Jul 2024 Humana Common 26,484 $510.24 Direct F4
holding HUM Restricted Stock Units 2,184 01 Jul 2024 Humana Common 2,184 Direct F5, F6
holding HUM Restricted Stock Units 4,573 01 Jul 2024 Humana Common 4,573 Direct F5, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

BRUCE D. BROUSSARD is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments.
F2 Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments on 2/22/22, 2/22/23, & 2/22/24.
F3 Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments on 2/21/23, 2/21/24, & 2/21/25.
F4 Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.
F5 Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
F6 Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.
F7 Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.
F8 Includes 21,786 restricted stock units granted on 2/21/24, representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.
F9 Shares transferred to GRAT effective January 30, 2024 in which reporting person is sole trustee.